Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 100
Summary
- Conditions
- Lung Cancer, Protection Against
- Lung Diseases
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 55 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03598309
- Collaborators
- James and Esther King Biomedical Research Program
- Investigators
- Principal Investigator: Nagi Kumar, Ph.D H. Lee Moffitt Cancer Center and Research Institute
Get Well Soon